
Dr. Richard Broth, M.D, MFM
Perinatologist and Director of TLC Perinatal, recognized for expertise in high-risk pregnancy care, advanced fetal diagnostics, and evidence-based approaches that improve maternal–neonatal outcomes.
Nuvo’s Advisory Board is powered by visionary leaders united in a shared commitment to make every pregnancy safer and more connected. With deep expertise across business, health, technology, maternal–fetal medicine, innovation, global health, AI, strategy, and marketing, they provide the insight and guidance that strengthen our mission to transform care for mothers and babies everywhere.

Perinatologist and Director of TLC Perinatal, recognized for expertise in high-risk pregnancy care, advanced fetal diagnostics, and evidence-based approaches that improve maternal–neonatal outcomes.

Senior executive and board / strategic advisor with 30+ years’ leadership in ultrasound, digital health, medical devices, AI and healthcare, including as SVP/GM of GE Healthcare’s ultrasound business.

Yale professor and leading MFM expert, and a pioneer in prenatal ultrasound and fetal diagnosis who has shaped global standards in high-risk pregnancy care and education. Former president of AIUM, SMFM, and ISUOG.

Former IBM Global Chief AI Officer and visionary leader at the intersection of AI, business transformation, and responsible innovation. Current CEO/founder of Aryalabs, an AI-based development platform.

OBGyn and maternal–fetal medicine specialist focused on heart disease and preeclampsia, leading Missouri PAMR/PQC and Nuvo Medicaid coverage, and directing a multi-site RCT on fetal telehealth.

Global marketing leader and tech entrepreneur who co-founded Allseated, drives innovation across startups and event tech, and advocates for maternal health and mental-health awareness.

Global business leader and former P&G Group President known for revitalizing major brands, leading digital transformation, and serving as the first woman chair of the APEC Business Advisory Council.

A veteran healthcare executive, investor, and Humana Chairman, with deep leadership experience in pharma services, M&A, and value creation across major healthcare organizations.

A prominent American Jewish communal leader, former CEO/Executive Vice Chair of the Conference of Presidents, and a longtime advocate for Israel and global Jewish affairs.

Healthcare investor and Longfellow Healthcare Partners founder and Managing Director, backing innovative services, digital health, and life-science companies with strategic, growth-focused leadership.

Named Southern California “Super Doctor” for many years; Board-certified OB/GYN and founder of Orange County OBGYN in Newport Beach, specializing in high-risk pregnancy care and surgical excellence.

Former J&J Group Chairman and Bausch+Lomb Chairman/CEO, known for driving global growth, innovation and values-based leadership, now advising and investing in healthcare and consumer companies worldwide.

Leading maternal–fetal medicine expert and ultrasound pioneer, former Cedars-Sinai Chair and UCLA Vice Chair, globally recognized researcher, educator, clinical innovator and author of 350+ papers.

Bulldog Capital Management founder, a pioneering $1B+ hedge fund acclaimed for top global performance and early investments in IPO-bound tech and life-science leaders; JD/MBA from Harvard University.

Renowned pediatric cardiologist, Director of the Fetal Heart Program at CHOP, global lecturer and author of 300+ publications, focused on prenatal foundations of lifelong cardiovascular health.

Professor of OBGYN, MFM specialist, and Director of Imaging at UPENN recognized for leadership in fetal assessment, prenatal imaging and expert care of complex, high-risk pregnancies.

Internationally recognized as Germany’s leading expert in obstetrics, gynecology, prenatal medicine, and gynecologic oncology, and for advancing ultrasound, fetal diagnostics and complex women’s healthcare.

Former head of Hadassah’s Ob/Gyn Ultrasound Unit, ISUOG Ian Donald Gold Medalist, global leader and pioneer in prenatal fetal imaging, 3D/4D diagnostics, preeclampsia research, and maternal–fetal innovation.
